Breast cancer experts release guidelines on use of aromatase inhibitors
Tuesday, July 13, 2010 - 02:21
in Health & Medicine
More than 100,000 women each year are diagnosed with a type of breast cancer called postmenopausal estrogen receptor-positive -- the most common type of breast cancer. Studies in recent years have shown that an important tool to prevent recurrence of this type of breast cancer lies in the use of medications called aromatase inhibitors.